| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
119,920,000 |
| Market
Cap: |
2.48(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.96 - $32.96 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Denali Therapeutics is a biopharmaceutical company that discovers and develops therapeutics to defeat neurodegenerative diseases. Co.'s clinical-stage programs are: leucine-rich repeat kinase 2 inhibitor program to address Parkinson's disease; enzyme transport vehicle :IDS program, its lead brain-penetrant enzyme replacement therapy, enabled by its enzyme transport vehicle, which is designed to restore iduronate 2-sulfatase, and reduce glycosaminoglycans, both peripherally and in the brain, in patients with mucopolysaccharidosis II; and eukaryotic initiation factor 2 B activator program to address diseases such as amyotrophic lateral sclerosis and frontotemporal dementia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
97,506 |
194,997 |
252,199 |
526,275 |
| Total Sell Value |
$1,994,341 |
$3,816,456 |
$5,294,638 |
$13,483,252 |
| Total People Sold |
2 |
5 |
5 |
6 |
| Total Sell Transactions |
4 |
19 |
38 |
76 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ho Carole |
Chief Medical Officer |
• – – |
2019-12-19 |
4 |
AS |
$20.00 |
$51,320 |
D/D |
(2,566) |
4,324 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-12-04 |
4 |
AS |
$18.00 |
$56,178 |
D/D |
(3,121) |
25,839 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-12-04 |
4 |
OE |
$5.28 |
$16,479 |
D/D |
3,121 |
28,960 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-12-04 |
4 |
AS |
$18.00 |
$47,808 |
I/I |
(2,656) |
580,710 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-12-04 |
4 |
AS |
$18.00 |
$337,590 |
I/I |
(18,755) |
2,429,304 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
AS |
$18.01 |
$12,805 |
D/D |
(711) |
25,839 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
OE |
$5.28 |
$3,754 |
D/D |
711 |
26,550 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
AS |
$18.01 |
$18,226 |
I/I |
(1,012) |
583,366 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-12-03 |
4 |
AS |
$18.02 |
$45,284 |
I/I |
(2,513) |
2,448,059 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-11-26 |
4 |
AS |
$18.02 |
$4,127 |
I/I |
(229) |
584,378 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-11-25 |
4 |
AS |
$18.02 |
$254,533 |
I/I |
(14,125) |
584,607 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-11-25 |
4 |
AS |
$18.02 |
$760,174 |
I/I |
(42,185) |
2,450,572 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-11-22 |
4 |
AS |
$18.00 |
$11,628 |
I/I |
(646) |
598,732 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-11-22 |
4 |
AS |
$18.00 |
$23,400 |
I/I |
(1,300) |
2,492,757 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-10-23 |
4 |
OE |
$5.28 |
$27,081 |
D/D |
5,129 |
25,839 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-09-09 |
4 |
AS |
$18.16 |
$136,200 |
I/I |
(7,500) |
610,089 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-09-05 |
4 |
AS |
$18.09 |
$87,682 |
I/I |
(4,847) |
2,494,057 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-09-03 |
4 |
AS |
$18.00 |
$67,212 |
I/I |
(3,734) |
2,498,904 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-08-21 |
4 |
D |
$18.60 |
$36,731 |
D/D |
(1,975) |
20,710 |
|
- |
|
| Krognes Steve E. |
CFO and Treasurer |
• – – |
2019-08-21 |
4 |
D |
$18.59 |
$36,745 |
D/D |
(1,977) |
1,003,666 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-08-21 |
4 |
D |
$18.59 |
$52,671 |
D/D |
(2,834) |
49,684 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,643 |
22,685 |
|
- |
|
| Krognes Steve E. |
CFO and Treasurer |
• – – |
2019-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,643 |
1,005,643 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,643 |
52,518 |
|
- |
|
| Crandell Keith |
10% Owner |
– – • |
2019-08-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(400,000) |
10,668,749 |
|
- |
|
426 Records found
|
|
Page 12 of 18 |
|
|
0.29 (1.42%) 
